objective response rate
Showing 1 - 25 of >10,000
Objective Response Rate Trial in Wuhan (GM-CSF)
Recruiting
- Objective Response Rate
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Feb 25, 2023
Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))
Recruiting
- Advanced Breast Cancer
- +2 more
- Trastuzumab Emtansine (T-DM1)
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Nov 5, 2023
Objective Response Rate (ORR) Trial (Envafolimab, Lenvatinib Combined With TACE)
Not yet recruiting
- Objective Response Rate (ORR)
- Envafolimab, Lenvatinib Combined With TACE
- (no location specified)
Oct 13, 2022
Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality
Recruiting
- Breast Cancer Stage IV
- comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
-
Mansoura, Dakahlia, EgyptOncology center mansoura university
Jan 1, 2023
Cancer, Melanoma Trial in Worldwide (Dabrafenib, Trametinib)
Completed
- Cancer
- Melanoma
-
Guangzhou, Guangdong, China
- +12 more
Jan 4, 2022
Recurrent Cervical Carcinoma, Metastatic Cervical Carcinoma, Persistent Cervical Carcinoma Trial in Beijing (Tislelizumab plus
Recruiting
- Recurrent Cervical Carcinoma
- +9 more
- Tislelizumab plus radiotherapy
-
Beijing, Beijing, ChinaLei Li
Apr 1, 2022
Fasting Mimicking Diet, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Netherlands (Fasting
Not yet recruiting
- Fasting Mimicking Diet
- +5 more
- Fasting Mimicking diet program
-
Alkmaar, Netherlands
- +14 more
Aug 15, 2022
Objective Response Rate Trial in Jinan (albumin-bound paclitaxe combined with bevacizumab biosimilar)
Recruiting
- Objective Response Rate
- albumin-bound paclitaxe combined with bevacizumab biosimilar
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Oct 7, 2021
Objective Response Rate Trial in Hangzhou (CD19 PD-1/CD28 CAR-T Plus Low Dose Decitabine)
Recruiting
- Objective Response Rate
- CD19 PD-1/CD28 CAR-T Plus Low Dose Decitabine
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 5, 2021
Recurrent Cervical Carcinoma, Radiotherapy, Epidermal Growth Factor Receptor Trial in Beijing (Combination of nimotuzumab and
Recruiting
- Recurrent Cervical Carcinoma
- +6 more
- Combination of nimotuzumab and radiotherapy
-
Beijing, Beijing, ChinaLei Li
Dec 18, 2020
Heart Failure, ICD, Chronotropic Incompetence Trial in La Jolla (CLS Mode on Biotronik CRT-D, Accelerometer Mode on Biotronik
Completed
- Heart Failure
- +2 more
- CLS Mode on Biotronik CRT-D
- Accelerometer Mode on Biotronik CRT-D
-
La Jolla, CaliforniaSulpizio Cardiovascular Center
Jul 14, 2021
Chemo, Anti-pd-1 Antibody, Cervical Neuroendocrine Carcinoma Trial in Beijing (Drug therapy)
Recruiting
- Chemotherapy
- +6 more
- Drug therapy
-
Beijing, Beijing, ChinaLei Li
Nov 15, 2020
Unresected Stage IIIb to IVM1c Melanoma Trial in Worldwide (Talimogene Laherparepvec)
Completed
- Unresected Stage IIIb to IVM1c Melanoma
- Talimogene Laherparepvec
-
Salt Lake City, Utah
- +41 more
Nov 26, 2021
Objective Structured Clinical Examination on Stress Among
Recruiting
- Heart Rate Variability
- +2 more
-
Clermont-Ferrand, Auvergne-Rhone-Alpes, France
- +1 more
Nov 14, 2023
Response Rate in Patients With Advanced NSCLC on ICI
Recruiting
- Non Small Cell Lung Cancer Metastatic
- Diabetes Mellitus
- Pembrolizumab
-
Assiut, EgyptAssiut university
Oct 20, 2023
Anesthesia, Pain, Acute Trial in Gothenburg (NoL)
Recruiting
- Anesthesia
- Pain, Acute
- NoL
-
Gothenburg, SwedenSahlgrenska University hospital
Jan 11, 2022
Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)
Completed
- Objective Response
- Overall Survival
- VIA combination treatment
-
Beijing, ChinaPeking University People's Hospital
Dec 9, 2022
Chronic Stroke, Weakness, Muscle Trial in Nashville (Average Force Production)
Recruiting
- Chronic Stroke
- Weakness, Muscle
- Average Force Production
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 11, 2023
Correlating Heart Rate Variability and Chronic Pain
Recruiting
- Chronic Pain
- Questionnaires, physical tests, and heart rate variability measures
-
Ottawa, Ontario, CanadaCanadian Forces Health Services Centre
Jul 19, 2022
Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Guangzhou (drug, radiation, procedure, other)
Recruiting
- Rectal Cancer
- +3 more
- Capecitabine, Oxaliplatin
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 19, 2022
Breathing Maneuvers for Inducible Myocardial Perfusion Deficits
Recruiting
- Coronary Artery Disease, Hyperventilation, Breath-hold, Pulse Rate
- 4 minute breathing maneuver
-
Montréal, Quebec, CanadaThe Research Institute of the McGill University Health Center
Aug 23, 2022
Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
Not yet recruiting
- Thrombopoietin Receptor Agonist
- (no location specified)
May 4, 2023
Infertility, Female, PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries Trial (metformin)
Not yet recruiting
- Infertility, Female
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- (no location specified)
Mar 2, 2023
"Online Surveys" in Perioperative Knee Anterior Cruciate
Not yet recruiting
- Anterior Cruciate Ligament Rupture
- knee brace cold therapy
- (no location specified)
Jun 14, 2022
Autonomic Dysfunction, Inflammatory Response, Chronic Kidney Diseases Trial in Taipei (heart rate variability biofeedback)
Recruiting
- Autonomic Dysfunction
- +2 more
- heart rate variability biofeedback
-
Taipei, TaiwanTri-Service Medical Center
Sep 26, 2022